MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

November 20, 2017

Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine Prevnar13 (PCV13), said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF). MSF is set to argue tomorrow in the High Court of Delhi that it should be overturned because the patent doesn’t meet the standards laid out in India’s Patents Act.

October 13, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières(MSF) filed a petition before the High Court of Delhi today to overturn a patent granted to Pfizer pharmaceutical corporation on the pneumococcal conjugate vaccine (PCV).

Ethiopia mental health
October 03, 2017

In recent years, severe drought and the resulting die-off of livestock have forced thousands of formerly nomadic people to settle near Galorgube, a small town in the Doolo Zone of Ethiopia’s Somali region. The situation has led to a humanitarian emergency in the area, with an acute malnutrition crisis and outbreaks of disease taking a heavy toll on the displaced population. The number of young children with severe acute malnutrition in Doolo Zone is now at the highest point in the ten years Doctors Without Border/Médecins Sans Frontières (MSF) has worked in the area.

August 22, 2017

Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that protects both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the U.S. pharmaceutical corporation Pfizer.

July 18, 2017

Malnutrition is reaching alarming levels in Ethiopia's Somali region. Voice of America spoke to Doctors Without Borders/Médecins Sans Frontières (MSF) emergency coordinator, Tara Newell, about the situation. View External Media. 

June 26, 2017

An acute humanitarian emergency is unfolding in Ethiopia's Somali region, with malnutrition reaching alarming levels, the international medical organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

MSF teams in the region’s Doolo Zone report 67 deaths of malnourished children so far in June.

"The numbers of young children with severe acute malnutrition in Doolo Zone are the highest our teams have seen in the area in the 10 years we have worked in the region," said Saskia van der Kam, MSF nutritional adviser.

June 26, 2017

As U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet at the White House today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that U.S. pressure on India to change its drug regulatory and patent system could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines. As an international medical humanitarian organization that relies on affordable generic medicines produced in India to run its medical programs in more than 60 countries, MSF urged Modi to stand strong and protect India’s role as the “pharmacy of the developing world.”

April 24, 2017

A massive outbreak of acute watery diarrhea is sweeping through Doolo zone, in Ethiopia’s Somali region, and it’s exacerbated by one of the worst droughts in 30 years.

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

Pages

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

November 20, 2017

Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine Prevnar13 (PCV13), said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF). MSF is set to argue tomorrow in the High Court of Delhi that it should be overturned because the patent doesn’t meet the standards laid out in India’s Patents Act.

October 13, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières(MSF) filed a petition before the High Court of Delhi today to overturn a patent granted to Pfizer pharmaceutical corporation on the pneumococcal conjugate vaccine (PCV).

Ethiopia mental health
October 03, 2017

In recent years, severe drought and the resulting die-off of livestock have forced thousands of formerly nomadic people to settle near Galorgube, a small town in the Doolo Zone of Ethiopia’s Somali region. The situation has led to a humanitarian emergency in the area, with an acute malnutrition crisis and outbreaks of disease taking a heavy toll on the displaced population. The number of young children with severe acute malnutrition in Doolo Zone is now at the highest point in the ten years Doctors Without Border/Médecins Sans Frontières (MSF) has worked in the area.

August 22, 2017

Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that protects both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the U.S. pharmaceutical corporation Pfizer.

July 18, 2017

Malnutrition is reaching alarming levels in Ethiopia's Somali region. Voice of America spoke to Doctors Without Borders/Médecins Sans Frontières (MSF) emergency coordinator, Tara Newell, about the situation. View External Media. 

June 26, 2017

An acute humanitarian emergency is unfolding in Ethiopia's Somali region, with malnutrition reaching alarming levels, the international medical organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

MSF teams in the region’s Doolo Zone report 67 deaths of malnourished children so far in June.

"The numbers of young children with severe acute malnutrition in Doolo Zone are the highest our teams have seen in the area in the 10 years we have worked in the region," said Saskia van der Kam, MSF nutritional adviser.

June 26, 2017

As U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet at the White House today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that U.S. pressure on India to change its drug regulatory and patent system could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines. As an international medical humanitarian organization that relies on affordable generic medicines produced in India to run its medical programs in more than 60 countries, MSF urged Modi to stand strong and protect India’s role as the “pharmacy of the developing world.”

April 24, 2017

A massive outbreak of acute watery diarrhea is sweeping through Doolo zone, in Ethiopia’s Somali region, and it’s exacerbated by one of the worst droughts in 30 years.

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

Pages